Alzheimer's drug faces limit
Ever since Medicare proposed to sharply limit coverage of the Alzheimer's drug Aduhelm, the agency has been deluged with impassioned pleas.
Ever since Medicare proposed to sharply limit coverage of the Alzheimer's drug Aduhelm, the agency has been deluged with impassioned pleas.